Showing results (1-10 of 7,332) with videos related to

Sort By:
Pageof 734
Technology in Cancer Research & Treatment|September 26, 2025
EfficientNetSwift: A Lightweight and Precise Deep Learning Model for Detecting Oral Squamous Cell Carcinoma Using Pathological ImagesMin Wu, Yue Hu, Fa Tian, et al.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion|April 13, 2012
[Treatment of infantile asthma in remission stage with Chinese medicine and new moxibustion-massage apparatus]Xin-Fa Tian, Zheng-Li Xu
Discover Oncology|January 24, 2026
Automatic and accurate auxiliary detection of lung cancer pathological classification based on novel lightweight deep learning modelShidong Wang, Fa Tian, Yupeng Niu
Journal of Environmental Management|March 24, 2004
Probe into the method of regional ecological risk assessment-a case study of wetland in the Yellow River Delta in ChinaXuegong Xu, Huiping Lin, Zaiyi Fu
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|April 18, 2024
Deep neural network uncertainty estimation for early oral cancer diagnosisHuiping Lin, Hanshen Chen, Jun Lin
American Journal of Alzheimer'S Disease and Other Dementias|January 20, 2026
The Impact of Inappropriate Sexual Behaviors in People With Dementia on Family Caregivers: A Scoping ReviewHuiping Lin, Leah Macaden, Colin Chandler
Expert Opinion on Investigational Drugs|October 16, 2021
Single and multiple dose pharmacokinetics and safety of ZSP1273, an RNA polymerase PB2 protein inhibitor of the influenza A virus: a phase 1 double-blind study in healthy subjectsYue Hu, Haijun Li, Min Wu, et al.
The International Journal of Neuroscience|March 27, 2013
MicroRNA-based therapy: a new dimension in epilepsy treatmentHao Liu, Mridul Roy, Fa-Fa Tian
Expert Opinion on Investigational Drugs|February 9, 2021
Pharmacokinetics and pharmacodynamics of MT-1207, a novel multitarget blocker of α1 receptor, 5-HT2A receptor, and calcium channel, in healthy subjectsHong Zhang, Min Wu, Yue Hu, et al.
Expert Opinion on Investigational Drugs|March 8, 2021
Safety, tolerability, and pharmacokinetics of the novel pan-phosphodiesterase inhibitor ZSP1601 in healthy subjects: a double-blinded, placebo-controlled first-in-human single-dose and multiple-dose escalation and food effect studyXiaoxue Zhu, Min Wu, Hong Wang, et al.
Pageof 734